Amphastar Pharmaceuticals, Inc. (AMPH)
16.87
-0.43
(-2.49%)
USD |
NASDAQ |
May 15, 16:00
16.88
+0.01
(+0.06%)
After-Hours: 20:00
Amphastar Pharmaceuticals Free Cash Flow : 132.94M for March 31, 2026
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Supernus Pharmaceuticals, Inc. | 82.24M |
| Amneal Pharmaceuticals, Inc. | 186.11M |
| Corcept Therapeutics, Inc. | 119.79M |
| Assertio Holdings, Inc. | -7.081M |
| Johnson & Johnson | 17.80B |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 47.84M |
| Cash from Investing (Quarterly) | -16.73M |
| Cash from Financing (Quarterly) | -30.21M |
| Free Cash Flow Per Share (Quarterly) | 0.8251 |
| Free Cash Flow to Equity (Quarterly) | 7.957M |
| Free Cash Flow to Firm (Quarterly) | 42.52M |
| Free Cash Flow Yield | 16.64% |